PIK3CA and breast cancer: Dysregulation of the phosphoinositide 3 (PI3)-kinase/Akt signaling pathway including through activating PIK3CA mutations, that are among the most common genetic alterations in breast cancer, particularly in luminal breast tumors [61], is associated with increased cancer cell growth, proliferation and survival.